PPARG and hepatocellular carcinoma: Since low hepatic Pparg2 mRNA levels are believed to contribute to the attenuation of the fatty liver phenotype in Shp−/− mice (12), PAA involvement in Pparg2 expression was assessed using a mouse hepatoma cell line (Fig. 7B).